Business Profile

Description: Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. View our community guidelines: http://bit.ly/2H9QmH5